Also known as: sFlt-1, sFlt, pre-eclampsia marker

Specimen requirements

Sample type: Serum

Collection requirements: No special requirements

Cost

Price on application

Turnaround time

Please see Turnaround times

Analytical method

Immunoassay

Analysis undertaken at these site(s)

John Radcliffe Hospital

Reference intervals

sFlt/PlGF ratio <=38 represents a very low risk (0.4%) of developing PET within 7 days.

sFlt/PlGF ratio >38 but <=85 represents an increased risk (20%) of developing PET within 7 days.

SFlt/PlGF ratio >85 represents a very high risk (55%) of developing PET within 7 days.

Results cannot be acted upon in isolation. Please correlate with clinical picture.